HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Er-Qing Wei Selected Research

pranlukast

4/2011Pranlukast attenuates hydrogen peroxide-induced necrosis in endothelial cells by inhibiting oxygen reactive species-mediated collapse of mitochondrial membrane potential.
4/2011Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
1/2009Pranlukast attenuates ischemia-like injury in endothelial cells via inhibiting reactive oxygen species production and nuclear factor-kappaB activation.
1/2007[Cysteinyl leukotriene receptor 1 antagonist pranlukast modulates differentiation of SK-N-SH cells].
11/2006Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury.
8/2005Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.
1/2005Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
12/2003Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats.
10/2002Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Er-Qing Wei Research Topics

Disease

23Brain Ischemia (Cerebral Ischemia)
01/2017 - 10/2002
13Ischemia
01/2017 - 01/2002
13Brain Injuries (Brain Injury)
10/2015 - 08/2005
9Gliosis
01/2017 - 08/2005
8Infarction (Infarctions)
01/2017 - 10/2002
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2017 - 10/2005
6Inflammation (Inflammations)
10/2015 - 02/2002
6Wounds and Injuries (Trauma)
06/2007 - 08/2005
5Necrosis
08/2013 - 02/2007
5Brain Edema (Cerebral Edema)
12/2012 - 10/2002
4Glioma (Gliomas)
01/2011 - 06/2007
3Encephalitis (Encephalitis, Rasmussen)
10/2015 - 06/2007
3Brain Diseases (Brain Disorder)
01/2012 - 10/2005
3Reperfusion Injury
05/2008 - 08/2007
3Neoplasms (Cancer)
01/2008 - 04/2006
2Glioblastoma (Glioblastoma Multiforme)
10/2015 - 01/2012
2Cicatrix (Scar)
06/2012 - 08/2005
2Atrophy
04/2011 - 02/2007
2Chronic Brain Injury
04/2011 - 01/2009
2Brain Neoplasms (Brain Tumor)
01/2008 - 06/2004
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2007 - 06/2004
1Brain Infarction
04/2011
1Nerve Degeneration
01/2011
1Parkinson Disease (Parkinson's Disease)
01/2011
1Hypoxia (Hypoxemia)
06/2007
1Neuritis (Polyneuritis)
01/2007
1Neuroblastoma
01/2007
1Edema (Dropsy)
11/2006

Drug/Important Bio-Agent (IBA)

13leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
08/2013 - 10/2002
11Neuroprotective AgentsIBA
04/2011 - 10/2002
9cysteinyl-leukotrieneIBA
12/2012 - 10/2004
9Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
06/2012 - 04/2006
9pranlukastIBA
04/2011 - 10/2002
8cysteinyl leukotriene receptor 2IBA
10/2015 - 11/2006
8LeukotrienesIBA
08/2013 - 04/2006
6Proteins (Proteins, Gene)FDA Link
01/2013 - 01/2007
5Nicotinamide PhosphoribosyltransferaseIBA
01/2017 - 01/2012
4Immunoglobulin G (IgG)IBA
11/2012 - 11/2006
4montelukast (Singulair)FDA Link
04/2011 - 10/2004
4Oxygen (Dioxygen)IBA
04/2011 - 01/2002
4Minocycline (Cyclops)FDA LinkGeneric
01/2010 - 10/2004
3Aquaporins (Water Channels)IBA
12/2012 - 01/2011
3N-Methylaspartate (NMDA)IBA
01/2011 - 08/2005
3Messenger RNA (mRNA)IBA
04/2010 - 01/2007
3Glucose (Dextrose)FDA LinkGeneric
01/2009 - 01/2002
3caffeic acidIBA
02/2007 - 04/2006
3Histamine (Histamine Dihydrochloride)FDA Link
01/2007 - 04/2002
2N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA
10/2015 - 01/2012
2NAD (NADH)IBA
10/2015 - 01/2012
23- (((3- carboxycyclohexyl)amino)carbonyl)- 4- (3- (4- (4- (cyclohexyloxy)butoxy)phenyl)propoxy)benzoic acidIBA
08/2013 - 11/2012
2Leukotriene D4IBA
08/2013 - 11/2006
2CytokinesIBA
08/2013 - 06/2012
2AntioxidantsIBA
04/2011 - 01/2007
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2011 - 01/2009
2Cilostazol (Pletal)FDA LinkGeneric
03/2011 - 02/2007
2Glial Fibrillary Acidic ProteinIBA
02/2011 - 01/2007
2NF-kappa B (NF-kB)IBA
01/2009 - 01/2008
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2009 - 06/2007
2Angiotensin IIIBA
05/2008 - 01/2008
2artemisinin (artemisinine)IBA
01/2008 - 06/2007
2artenimol (dihydroartemisinin)IBA
01/2008 - 06/2007
2Dizocilpine Maleate (Dizocilpine)IBA
02/2007 - 12/2005
2baicalinIBA
02/2007 - 08/2005
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2007 - 04/2006
2Histidine (L-Histidine)FDA Link
12/2005 - 04/2002
2Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
12/2003 - 10/2002
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2003 - 02/2002
1Interleukin-6 (Interleukin 6)IBA
01/2017
1LipopolysaccharidesIBA
10/2015
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2015
13-methyladenineIBA
10/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013
1InterleukinsIBA
08/2013
1Conditioned Culture MediaIBA
08/2013
1Dihydrotachysterol (AT 10)IBA
11/2012
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2012
1Growth InhibitorsIBA
01/2012
1Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2011
1Acetylcysteine (Siran)FDA LinkGeneric
04/2011
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
04/2011
1Matrix Metalloproteinases (MMPs)IBA
04/2011
1VimentinIBA
02/2011
1ColforsinIBA
01/2011
1RotenoneIBA
01/2011
1Masoprocol (Actinex)FDA Link
04/2010
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2010
1huanglian-jie-du decoctionIBA
01/2009
1NF-KappaB Inhibitor alphaIBA
01/2008
1Free RadicalsIBA
01/2008
1pyrrolidine dithiocarbamic acidIBA
01/2008
1prolinedithiocarbamate (PDTC)IBA
01/2008
1Temozolomide (Temodar)FDA LinkGeneric
01/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2007
1Deferoxamine (Desferal)FDA LinkGeneric
06/2007
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2007
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
02/2007
1Phosphodiesterase 3 InhibitorsIBA
02/2007
1AcidsIBA
01/2007
1Histamine Receptors (Histamine Receptor)IBA
01/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2008